EntryPoint Capital »

Ocuphire Pharma shares owned by EntryPoint Capital

Quarter-by-quarter ownership of Ocuphire Pharma (IRD) shares owned by EntryPoint Capital from 13F filings

Historical chart of EntryPoint Capital investment in Ocuphire Pharma

Tip: Access up to 7 years of quarterly data

All positions including Ocuphire Pharma held by EntryPoint Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Ocuphire Pharma by EntryPoint Capital

Quarter filed Position value Share count Share price at filing
2026-06-30 $209k 51k 4.11

More positions owned by EntryPoint Capital

Standardaero (SARO)
Howmet Aerospace (HWM)
Benchmark Electronics (BHE)
Capital One Financial (COF)
Hayward Hldgs (HAYW)
Huntington Bancshares Incorporated (HBAN)
Bank of America Corporation (BAC)
RBC Bearings Incorporated (RBC)
Gilead Sciences (GILD)
Avient Corp (AVNT)
Donaldson Company (DCI)
Universal Display Corporation (OLED)
Helios Technologies (HLIO)
HEICO Corporation (HEI)
American Homes 4 Rent Cl A (AMH)

View all positions for EntryPoint Capital

Top funds holding Ocuphire Pharma

Caligan Partners
Adage Capital Partners GP
BIOS Capital Management
BlackRock
Balyasny Asset Management
Nantahala Capital Management
Vanguard Capital Management
Boxer Capital Management
Trails Edge Capital Partners
Millennium Management
Dr. Jeffrey R. Jay, M.D.
Marshall Wace
ADAR1 Capital Management
Goldman Sachs Group
Woodline Partners

View all funds holding Ocuphire Pharma